Stable iodine ingestion by adults in the case of a nuclear accident: An approach to comparing the benefits and risks;Ingestion d'iode stable chez l'adulte en cas d'accident nucléaire: Une approche pour comparer les bénéfices et les risques

Environnement, Risques et Sante

Volumn 1, Issue 3, 2002, Pages 149-156

  Croq, Michel ^a   Catelinois, Olivier ^b   Verger, Pierre ^c  

^a Service de Protection Radiologique des Armees   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^c Observ Regl S Provence A C A   (France)

Author keywords

Accidents, radiation; Hyperthyroidism; Iodine; Prophylaxis; Risk assessment; Study comparative

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; FRANCE; HEALTH HAZARD; HUMAN; HYPERTHYROIDISM; INGESTION; IONIZING RADIATION; MEDICAL ASSESSMENT; MEDICAL LITERATURE; NUCLEAR ACCIDENT; NUCLEAR POWER PLANT; PROPHYLAXIS; RADIATION EXPOSURE; RISK FACTOR; RUSSIAN FEDERATION; THYROID CANCER; URBAN AREA;

EID: 0037593410     PISSN: 16350421     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Baverstock K, Blomqvist L, Klein G, Paile W, Repacholi M. Guidelines for iodine prophylaxis following nuclear accidents. Geneva: World Health Organization, 1999; 39 p.
2. CSHPF (Conseil Supérieur d'Hygiène Publique de France). Prévention des conséquences d'une contamination par les isotopes radioactifs de l'iode au moyen d'iode stable. Bulletin officiel du ministère de la Santé, 12 décembre 1998: 155-6.
3. Verger P, Aurengo A, Geoffroy B, Le Guen B. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: a review. Thyroid 2001; 11: 353-60.
4. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). Sources and effects of ionizing radiation. Report to the general Assembly. New York: United Nations, 2000; 654 p.
5. Akiba S, Lubin J, Ezaki H. Thyroid cancer incidence among atomic bomb survivors in Hiroshima and Nagasaki 1958-79. Hiroshima: Radiation Effects Research Fundation, 1991: 5-91.
6. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994; 137: S17-67.
7. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 259-77.
8. Boice JD Jr. Radiation and thyroid cancer: what more can be learned? [editorial]. Acta Oncol 1998; 37: 321-4.
9. Schlumberger M. Tumeurs de la thyroïde après irradiation. Ann Endocrinol 1995; 56: 133-9.
10. Hoffman D. Late effects of I-131 therapy in the United Stated. In: Radiation Carcinogenesis: Epidemiology and biological significance, Boice FJ J, ed. New York: Raven Press, 1984: 273-80.
11. Holm LE, Wiklund KE, Lundell GE, et al. Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study [see comments]. J Natl Cancer Inst 1988; 80: 1132-8.
12. Holm LE, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991; 83: 1072-7.
13. Delange F, de Benoist B, Alnwick D. Risks of iodine-induced hyperthyroidism after correction of iodine deficiency by iodized salt. Thyroid 1999; 9: 545-56.
14. Ek B, Johnsson S, Von Porat B. Iodide repletion test in an endemic goitre area. Risk of iodine-induced hyperthyroidism. Acta Medica Scand 1963; 173: 341-8.
15. Robison LM, Sylvester PW, Birkenfeld P, Lang JP, Bull RJ. Comparison of the effects of iodine and iodide on thyroid function in humans. J Toxicol Environ Health 1998; 55: 93-106.
16. Blum M, Weinberg U, Shenkman L, Hollander CS. Hyperthyroidism after iodinated contrast medium. N Engl J Med 1974; 291: 24-5.
17. Reinwein D, Benker G, Konig MP, Pinchera A, Schatz H, Schleusener H. Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey. J Endocrinol Invest, 1986; 9: 1-36.
18. Laurie AJ, Lyon SG, Lasser EC. Contrast material iodides: potential effects on radioactive iodine thyroid uptake. J Nucl Med 1992; 33: 237-8.
19. Steidle B. Iodine-induced hyperthyroidism after contrast media: animal experimental and clinical studies. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd 1989; 128: 6-14.
20. Martin FI, Tress BW, Colman PG, Deam DR. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med 1993; 95: 78-82.
21. Nolte W, Muller R, Siggelkow H, Emrich D, Hufner M. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 1996; 134: 337-41.
22. Hintze G, Blombach O, Fink H, Burkhardt U, Kobberling J. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol 1999; 140: 264-7.
23. Vidor GI, Stewart JC, Wall JR, Wangel A, Hetzel BS. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania. J Clin Endocrinol Metab 1973; 37: 901-9.
24. Burgi H, Kohler M, Morselli B. Thyrotoxicosis incidence in Switzerland and benefit of improved iodine supply. Lancet 1998; 352: 1034.
25. Mostbeck A, Galvan G, Bauer P, et al. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med 1998; 25: 367-74.
26. Buttfield IH, Hetzel BS. Endemic goitre in eastern New Guinea, with special reference to the use of iodized oil in prophylaxis and treatment. Bull WHO 1967;36:243-62.
27. Maberly GF, Corcoran JM, Eastman CJ. The effect of iodized oil on goitre size, thyroid function and the development of the Jod Basedow phenomenon. Clin Endocrinol (Oxford) 1982; 17: 253-9.
28. Martins MC, Lima N, Knobel M, Medeiros-Neto G. Natural course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area: a 5-year follow-up. J Endocrinol Invest 1989; 12: 239-44.
29. Elnagar B, Eltom M, Karlsson FA, Ermans AM, Gebre-Medhin M, Bourdoux P. The effects of different doses of oral iodized oil on goiter size, urinary iodine, and thyroid-related hormones. J Clin Endocrinol Metab 1995; 80: 891-7.
30. Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993; 94: 524-32.
31. Laurberg P, Bulow Pedersen I, Pedersen KM, Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. Thyroid 1999; 9: 33-8.
32. Fadel BM, Ellahham S, Ringel MD, Lindsay J, Wartofsky L, Burman KD. Hyperthyroid heart disease. Clin Cardiol 2000; 23: 402-8.
33. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid 1998; 8: 101-6.
34. Vlase H, Lungu G, Vlase L. Cardiac disturbances in thyrotoxicosis: diagnosis, incidence, clinical features and management. Endocrinologie 1991; 29: 155-60.
35. Kahaly GJ, Nieswandt J, Mohr-Kahaly S. Cardiac risks of hyperthyroidism in the elderly. Thyroid 1998; 8: 1165-9.
36. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992; 327: 94-8.
37. Hennersdorf MG, Strauer BE. Cardiac arrhythmias in hyperthyroidism. Dtsch Med Wochenschr 2000; 125: 637-41.
38. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998; 83: 765-9.